Physician profile
Claudio Benadiva
NPI 1003985805
$22,432.69
in general payments reported to CMS, 2019-2025
6 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 92% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,288 · 2020: $49.07 · 2021: $1,437 · 2022: $12K · 2023: $718 · 2024: $233 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325 · Consulting Fee: $600 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.06 |
| Consulting Fee | $600.00 |
| Education | $172.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $18,846.44 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $1,577.90 | 2019-2025 | Stripper |
| Merck Sharp & Dohme LLC | $1,356.64 | 2019-2021 | |
| Organon LLC | $326.45 | 2021-2025 | Pregnyl, Ganirelix Acetate |
| Emd Serono, INC. | $198.25 | 2019-2023 | |
| Ferring International Pharmascience Center US | $127.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudio Benadiva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.